Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …

Colloidal nanoparticles (NPs) have attracted significant attention due to their unique
physicochemical properties suitable for diagnosing and treating different human diseases …

Aggregation of amyloid‐β protein (Aβ) is a pathological hallmark of Alzheimer's disease
(AD), so the inhibition of Aβ aggregation is an important strategy for the prevention and …

Gold nanoparticles (Au NPs) have attracted much attention due to their potential
applications in nanomedicine. While numerous studies have quantified biomolecular …

The progress achieved over the last three decades in the field of bioconjugation has
enabled the preparation of sophisticated nanomaterial–biomolecule conjugates, referred to …

Formation of a protein corona around nanoparticles when immersed into biological fluids is
well-known; less studied is the formation of lipid coronas around nanoparticles. In many …

Quadruple aberrant hyperphosphorylated tau, beta-amyloid, α-synuclein and TDP-43
neuropathology and metal solid nanoparticles (NPs) are documented in the brains of …

Inhibition of amyloid β (Aβ) aggregation holds considerable promise as a therapeutic
strategy for Alzheimer's disease (AD). However, successful inhibition is hard to achieve due …

Background: Although a variety of therapeutic approaches are available for the treatment of
Parkinson's disease, challenges limit effective therapy. Among these challenges are delivery …

The corona that forms as protein adsorbs to gold nanospheres (AuNSs) is directly influenced
by the surface chemistry of the AuNS. Tools to predict adsorption outcomes are needed for …